EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY-NC 4.0

Characteristics and management of low‐level viraemia in people living with HIV in a resource‐limited setting: A multicentre retrospective study in Greece

Lydia Leonidou iD, Giota Lourida iD, Konstantinos Protopapas iD, Charalampos D Moschopoulos iD, Dimitrios Zoulas iD, Charisis Totsikas iD, Dimitrios Basoulis iD, Elpida Mastrogianni, Apostolos Beloukas iD, Maria Lagadinou iD, Markos Marangos, Vasileios Papastamopoulos iD und 2 weitere

HIV Medicine · 2026

DOI: 10.1111/hiv.70295 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift HIV Medicine, 2026. Verfasst von Lydia Leonidou und 13 weiteren Autor:innen. Beteiligte Einrichtung: University of Patras Medical School, Patras, Greece. Hauptthemen laut MEDLINE: Anti-HIV Agents, HIV Infections, HIV-1, Viremia. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Low‐level viraemia (LLV) persists in some people living with HIV despite antiretroviral therapy, raising concerns about virologic failure. We assessed the characteristics, management and outcomes of LLV in Greece, where next‐generation sequencing, therapeutic drug monitoring and electronic adherence monitoring are unavailable.

Methods

This retrospective multicentre study included people living with HIV from four Greek clinics who had achieved virological suppression for at least 6 months. LLV was defined as two consecutive HIV‐1 RNA measurements between 51 and 200 copies/mL. Patients were followed for 18 months, during which three subsequent viral load measurements were evaluated. Adherence was assessed using patient self‐report and documentation in the medical record.

Results

Among 3800 patients, 35 (0.9%) experienced LLV. Median age was 49 years, and 69% were male. Patients were treatment‐experienced (median 3.5 ART lines; median duration of viral suppression, 7 years), with 57% receiving high genetic‐barrier regimens. Baseline genotypic resistance data were available for 30 of 35 patients (85.7%), and clinically relevant resistance‐associated mutations were identified in 6 (20.0%). LLV resolved in 27 of 35 patients (77.1%), persisted in 7 (20.0%) and recurred in 1 (2.9%). No patient developed virologic failure. Presumed causes of LLV were unknown in 18 (51.4%), low adherence in 14 (40.0%) and drug–drug interactions in 3 (8.6%). ART was modified in 17 patients, of whom 13 (76.5%) achieved viral resuppression, most commonly after switching from lower‐ to higher‐genetic‐barrier regimens. One patient with persistent LLV developed lymphoma during follow‐up.

Conclusions

LLV was uncommon but clinically relevant in this multicentre Greek cohort and frequently resolved following targeted management. Adherence optimization and ART modification, particularly to higher genetic‐barrier regimens, were associated with viral resuppression in this cohort. Ongoing monitoring remains essential, especially in settings with limited access to advanced diagnostic tools.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-HIV AgentsHIV InfectionsHIV-1ViremiaAdultFemaleHumansMaleMiddle AgedDrug MonitoringDrug Resistance, ViralGreeceRetrospective StudiesRNA, ViralViral Load

Stichwörter der Autor:innen

HIVadherenceantiretroviral therapylow‐level viraemiaresource‐limited settings

Substanzen

Anti-HIV AgentsRNA, Viral

Autor:innen und Institutionen

  • University of Patras Medical School, Patras, Greece.
  • Division of Infectious Diseases, University General Hospital of Patras, Patras, Greece.
  • Infectious Diseases Department, Evangelismos General Hospital, Athens, Greece.
  • 4th Department of Internal Medicine, School of Medicine, Attikon University Hospital, Athens, Greece.
  • Blood Bank Department, Evangelismos General Hospital, Athens, Greece.
  • 1st Department of Internal Medicine, Laiko General Hospital, Athens, Greece.

ORCID-Profile: Lydia Leonidou, Giota Lourida, Konstantinos Protopapas, Charalampos D Moschopoulos, Dimitrios Zoulas, Charisis Totsikas, Dimitrios Basoulis, Apostolos Beloukas, Maria Lagadinou, Vasileios Papastamopoulos, Antonios Papadopoulos

Zitieren

APA

Leonidou, L., Lourida, G., Protopapas, K., Moschopoulos, C. D., Zoulas, D., Totsikas, C., Basoulis, D., Mastrogianni, E., Beloukas, A., Lagadinou, M., Marangos, M., Papastamopoulos, V., Papadopoulos, A., & Psichogiou, M. (2026). Characteristics and management of low‐level viraemia in people living with HIV in a resource‐limited setting: A multicentre retrospective study in Greece. HIV Medicine. https://doi.org/10.1111/hiv.70295

Vancouver

Leonidou L, Lourida G, Protopapas K, Moschopoulos CD, Zoulas D, Totsikas C, et al. Characteristics and management of low‐level viraemia in people living with HIV in a resource‐limited setting: A multicentre retrospective study in Greece. HIV Medicine. 2026. doi:10.1111/hiv.70295

BibTeX
@article{Leonidou2026,
  author = {Leonidou, Lydia and Lourida, Giota and Protopapas, Konstantinos and Moschopoulos, Charalampos D and Zoulas, Dimitrios and Totsikas, Charisis and Basoulis, Dimitrios and Mastrogianni, Elpida and Beloukas, Apostolos and Lagadinou, Maria and Marangos, Markos and Papastamopoulos, Vasileios and Papadopoulos, Antonios and Psichogiou, Mina},
  title = {Characteristics and management of low‐level viraemia in people living with HIV in a resource‐limited setting: A multicentre retrospective study in Greece},
  journal = {HIV Medicine},
  year = {2026},
  doi = {10.1111/hiv.70295}
}
Kostenlos starten →